EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

EEDGAR/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice. EDGAR is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. EDGAR/calls is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›XWEL

XWEL

XWELL, Inc.

Next earnings Aug 12, 2026

Last earnings +0.9% on 2026-04-01

Avoid
$1.06
▲ +1.92%
$1.06▲ +12.77%
over 1Y
L $0.29EODHDH $1.70
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+1.9%
1W-7.0%
1M-23.2%
3M-11.7%
YTD+135.6%
1Y+12.8%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Avoid
Quality
F
Valuation
Fair value
Filings
Flagged
Avoid
Conviction
Horizon
Medium (3–12mo)
Street · 7 analysts
Buy

Conservative balance sheet (liabilities/equity -1.07x); but revenue fell -13.8% YoY.

Revenue (FY2025) $29.2M · FY2025

XWELL, Inc. shows $29.2M in FY2025 revenue (-13.8% YoY), a -58.2% net margin.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue$73.7M$55.9M$30.1M$33.9M$29.2M
Gross profit$32.3M$12.0M$3.68M$8.92M$7.51M
Operating income$4.11M-$31.2M-$28.2M-$16.7M-$15.7M
Net income$3.35M-$32.8M-$27.7M-$16.9M-$17.0M
Diluted EPS$0.03-$7.01-$6.64-$3.66-$5.08
Net margin4.5%-58.7%-92.1%-49.7%-58.2%

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$15.9M
EV / EBITDA—
EV / Sales0.5
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield-202.2%
FCF yield-139.0%

Quality & risk

ROIC (est.)—
Free cash flow-$11.7M
Total debt$10.1M
Net cash-$7.47M
Altman Z-Score-63.66 distress
Piotroski F-Score2/9

Capital returns

Buyback yield283.1%
Dividend yield (est.)—
Shareholder yield283.1%
Shares Δ YoY+50.7%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Red flag in recent filings — late filing notice (2026-05-15). Worth a closer look.
  1. 10-Q Quarterly report2026-05-20
  2. NT 10-Q Late filing notice2026-05-15
  3. 10-K/A Restated periodic report2026-04-30
  4. 8-K/A Amended 8-K2026-04-10
  5. 8-K Earnings results2026-04-01
  6. S-3 Shelf registration (potential raise)2026-04-01
  7. 10-K Annual report2026-04-01
  8. NT 10-K Late filing notice2026-04-01
  9. 8-K Material agreement2026-03-04

Recent filings

all on EDGAR ↗
SCHEDULE 13GFiling2026-06-11open ↗10-QPeriod ending 2026-03-312026-05-20open ↗NT 10-QPeriod ending 2026-05-152026-05-15open ↗10-K/APeriod ending 2025-12-312026-04-30open ↗424B3Filing2026-04-16open ↗EFFECTFiling2026-04-15open ↗CORRESPFiling2026-04-14open ↗UPLOADFiling2026-04-13open ↗8-K/APeriod ending 2025-12-182026-04-10open ↗S-3Filing2026-04-01open ↗8-KPeriod ending 2026-04-012026-04-01open ↗10-KPeriod ending 2025-12-312026-04-01open ↗

Quality score

F
ValueGrowthProfitHealthMom.
ValueA+
GrowthF
ProfitabilityF
Financial healthF
Momentum—
  • ✗Revenue growing year-over-year
  • ✗Profitable (positive net income)
  • ✗Net margin above 10%
  • ✓Liabilities below 2× equity
Revenue
$29.2M
-13.8% YoY
Net margin
-58.2%
ROE
—
P/E
—

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$29.2M-13.8%
Net income-$17.0M-0.8%
Gross profit$7.51M-15.8%
Operating income-$15.7M+6.2%
Diluted EPS-$5.08-38.8%
Cash & equivalents$2.62M-42.5%
Total assets$11.2M-55.8%
Total liabilities$23.8M+35.1%
Stockholders' equity-$22.3M-2725.1%
Gross: 25.7%Op.: -53.6%L/E: -1.07x

Frequently asked

Is XWELL, Inc. (XWEL) a buy?
XWEL currently carries a Avoid rating with 4/5 conviction, derived from its latest SEC filings. Conservative balance sheet (liabilities/equity -1.07x); but revenue fell -13.8% YoY.
What is XWELL, Inc.'s quality score?
XWEL scores 37.88235294117647/100 (grade F) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001410428, latest 10-Q filed 2026-05-20) · EODHD · as of 6/26/2026, 8:01:00 PM.

Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC
2026-02-27
WEINSTEIN ROBERT
Director
Award100K
2026-02-27
Lebowitz Michael
Director
Award100K
2026-02-27
Ernst Ezra
President and CEO
Award100K
2026-02-27
Bernstein Bruce
Director
Award100K
2026-02-27
Wizenberg Gaelle Sandra
Director
Award100K
2025-08-01
Ernst Ezra
President and CEO
Award70.0K
2025-06-02
Wizenberg Gaelle Sandra
Director
Award89.2K
2025-06-02
Lebowitz Michael
Director
Award98.1K

Earnings history

beat/miss · move
2026-04-01—▲ +0.87%8-K ↗
2025-11-14—▲ 0.00%8-K ↗
2025-08-14—▼ -2.44%8-K ↗
2025-05-20—▼ -1.08%8-K ↗
2025-04-15—▼ -2.60%8-K ↗
2024-11-14—▼ -1.18%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Recent news

market news →
XWELL (XWEL): 10 Unstoppable Stocks That Could Double Your MoneyBullish
finance.yahoo.com· 2026-04-20
Trump family-linked group backs XWell’s AI airport screening push - reportBullish
seekingalpha.com· 2026-04-06
Penny Stock XWELL Is Up More Than 300% Today. Why, and Should You Chase the Rally Here?Bullish
finance.yahoo.com· 2026-02-25
BC-Most Active StocksBullish
finance.yahoo.com· 2026-02-25
XWELL Reports Third Quarter 2025 ResultsBullish
globenewswire.com· 2025-11-14
XWELL Strengthens Florida Presence with Bloomingdale Wellness Center Grand OpeningBullish
globenewswire.com· 2025-09-12

Vs tracked universe

compare →

1044 tracked peers · median

EDGAR Score38 vs 67
Revenue growth-13.8% vs 7.1%
Net margin-58.2% vs 10.5%
Return on equity— vs 12.3%
P/E— vs 25.5